Table 3.
Management of bladder cancer in the included population.
| ID | Presentation | Urine cytology | Histology after TURBT | Urinary diversion associated with RC | Histology after RC | Staging after RC | Complications after RC |
|---|---|---|---|---|---|---|---|
| 1 | M | N | TCC T1 HG | UCS | SCC + TCC nested | pT1,N0 | Hyperpyrexia |
| 2 | M | P | TCC T1 HG + CIS | Bricker’s ileal conduit | TCC + CIS | pT3a,N0 | Anemia |
| 3 | M | N | TCC T2 HG | UCS | TCC | pT2b,N2 | None |
| 4 | M | NP | SCC T1 | Bricker’s ileal conduit | SCC | pT2a,N0 | Urinary fistula |
| 5 | M | N | TCC T1 HG | Orthotopic ileal neobladder | TCC + CIS | pT2a,N0 | Surgical revision of anastomosis |
| 6 | M | N | TCC T2 HG | UCS | SCC + TCC | pT4a,Nx,M1 | Paralytic ileus |
| 7 | M | NP | – | Bricker’s ileal conduit | SCC | pT4a,Nx,M2 | Hyperpyrexia, Anemia |
| 8 | M | N | SCC T1 | Bricker’s ileal conduit | SCC | pT2a,N0 | Wound dehiscence requiring surgery |
| 9 | M | N | SCC T2 | Bricker’s ileal conduit | SCC + metaplasia | pT2a,Nx,Mx | Wound dehiscence requiring surgery |
| 10 | M | NP | TCC T1 HG + CIS | Bricker’s ileal conduit | TCC + CIS | pTis,Nx | Paralytic ileus |
| Cases: 10 | M: 10/10 (100%) | N: 6/7 (85.7%) | TCC: 6/9 (66.7%) | Bricker’s ileal conduit: 6/10 (60%) | SCC: 6/10 (60%) | T1: 1/10 (10%) | Cases with post-operative complications: 9/10 (90%) |
| P: 1/7 (14.3%) | -T1 HG: 4/9 (44.4%) | UCS: 3/10 (30%) | TCC: 4/10 (40%) | Tis: 1/10 (10%) | Cases with no post-operative complications: 1/10 (10%) | ||
| NP: 3/10 (30%) | -CIS: 2/9 (22.2%) | Neobladder: 1/10 (10%) | CIS: 3/10 (30%) | T2: 5/10 (50%) | |||
| -T2 HG: 2/9 (22.2%) | T3: 1/10 (10%) | ||||||
| SCC: 3/9 (33.3%) | T4: 2/10 (20%) | ||||||
| -T1: 2/10 (22.2%) | |||||||
| -T2: 1/10 (11.1%) |
CIS carcinoma in situ, HG high grade, M macrohematuria, N negative, NP not performed, P positive, RC radical cystectomy, SCC squamous cell carcinoma, TCC transitional cell carcinoma, TURBT transurethral resection of bladder tumor, UCS ureterocutaneostomy.